2.63
0.27 (11.44%)
0.27 (11.44%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.81
High
5.80
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.27 | 11.44% | 2.63 | 19:59:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.34 | 2.3166 | 2.80 | 2.74 | 2.36 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.61 | 2.63 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 37,071 | 18,629,275 | $ 2.44 | $ 45,454,406 | 8,822,009 | 0.81 - 5.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:52 | formt | 200 | $ 2.63 | USD |
Atossa Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 317.77M | 120.82M | 120.77M | $ - | $ - | -1.97 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 0.50% |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.37 | 2.80 | 2.15 | 2.37 | 12,872,178 | 0.26 | 10.97% |
| 1 Month | 2.04 | 2.80 | 1.48 | 2.14 | 9,920,063 | 0.59 | 28.92% |
| 3 Months | 2.98 | 3.78 | 1.48 | 2.56 | 10,969,637 | -0.35 | -11.74% |
| 6 Months | 1.54 | 4.90 | 0.81 | 2.40 | 15,189,296 | 1.09 | 70.78% |
| 1 Year | 1.65 | 5.80 | 0.81 | 2.43 | 7,732,447 | 0.98 | 59.39% |
| 3 Years | 4.02 | 7.39 | 0.755 | 2.63 | 3,058,513 | -1.39 | -34.58% |
| 5 Years | 48.60 | 68.22 | 0.755 | 4.14 | 2,429,023 | -45.97 | -94.59% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
